Version 5.4
Bos taurus Protein: SLC23A2
Summary
InnateDB Protein IDBP-692002.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol SLC23A2
Protein Name solute carrier family 23 (nucleobase transporters), member 2
Synonyms SLC23A1;
Species Bos taurus
Ensembl Protein ENSBTAP00000039151
InnateDB Gene IDBG-639799 (SLC23A2)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
Predicted by orthology
Total 2 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005215 transporter activity
GO:0015229 L-ascorbic acid transporter activity
GO:0070890 sodium-dependent L-ascorbate transmembrane transporter activity
Biological Process
GO:0006810 transport
GO:0015882 L-ascorbic acid transport
GO:0055085 transmembrane transport
GO:0070904 transepithelial L-ascorbic acid transport
Cellular Component
GO:0005886 plasma membrane
GO:0016020 membrane
GO:0016323 basolateral plasma membrane
GO:0016324 apical plasma membrane
Protein Structure and Domains
PDB ID
InterPro IPR006043 Xanthine/uracil/vitamin C permease
PFAM PF00860
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL E1BP61
UniProt Splice Variant
Entrez Gene 783536
UniGene Bt.61948
RefSeq NP_001192359
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02036027 DAAA02036028
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca